Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (282)	3/7/2007 3:52:04 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Of my three pet stocks (ands, infi, glgc) I own some Anadys and that is holding up fine around $3.5 --I have a small position in Infinity which seems to be falling lately. And I hope to buy back glgc later this year. GLGC has held up remarkably well in the lousy market-- however I think I can take the chance and be out of the stock til autumn. I'm sure that I heard it correctly on the CC that there will be no decisions on any molecules this year, and therefore no milestone payments. So, just burn this year. Of course by that logic why own any of them, ands infi or glgc! I once made a point about liquidity--limited supply and a hyper market drove this very high in '99. But even in a lousy market, one buyer with deep pockets may be more than enough to support these shares. I may have botched things giving mine up. I'll feel silly if this just steadily climbs all year long.